Matinas BioPharma (MTNB)

• Market cap: $4.72M
• 1 day: -1.9%
• 5 days: -19.67%
• 1 month: -38.73%
• 3 months: -56.18%
• 6 months: -20.9%
• Year to date: 22.96%
• 1 year: 21.51%
• 5 years: -98.65%
• 10 years: -99.62%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Employees: 34